Seneca Partners
Seneca – Manager Overview
Who is Seneca?
The Seneca EIS Portfolio Service is provided by Seneca Capital in partnership with Acceleris Limited.
Seneca Capital is Investment Adviser to the Portfolio Service and is responsible for sourcing suitable investment opportunities and advising on the structuring, valuation and execution of these investments. Seneca Capital will also advise on the strategic development of these Investee Companies throughout the investment period and on the options available to realise each investment once the Three Year Period has ended.
Acceleris, as Portfolio Manager, will be responsible for the management of each Investor’s portfolio until such time as Seneca Partners is granted appropriate permissions from the FSA.
About Seneca Capital
Seneca Capital is a wholly-owned subsidiary of Seneca Partners Limited, an independent investment and corporate finance business for private individuals, entrepreneurs, companies, funds and charities. Their team brings together decades of success in providing investment solutions and success for investors.
With offices in Manchester, Leeds and Birmingham, Seneca Capital maintains a strong local presence in the SME heartlands and the established, trusted and high quality contact networks of the Seneca Capital team, which includes fellow professionals, funders, investors and SMEs themselves, is critical to the ability of the Seneca Capital team to source the most interesting and compelling investment opportunities.
About Acceleris
Acceleris is a corporate finance house specialising in arranging and managing investments by private individuals under EIS. Since formation in 2000 Acceleris has completed more than 70 transactions and raised more than £25 million. The EIS expertise and knowledge that lies within the Acceleris team is a key part of the Seneca EIS Portfolio Service.
Acceleris’ success as a specialist EIS investment manager has been underlined by a number of recent awards for both Acceleris themselves and for the companies for which Acceleris has raised equity from private investors under the Enterprise Investment Scheme.
The awards include:
November 2011
Microvisk Technologies won the Healthcare Project of the Year Award and Redx Pharma was named Start-Up Company of the Year at the prestigious BioNow Biomedical Awards which showcased the leading biomedical companies in the North West of England. Acceleris completed multiple fundraisings for these businesses under the Enterprise Investment Scheme.
September 2011
Memsstar was named the 20th fastest-growing technology company in the UK in The Sunday Times Microsoft Tech Track 100 for 2011. Acceleris led an equity fundraising under the Enterprise Investment Scheme for this company in April 2007.
June 2011
RedX Pharma won Knowledge Business of the Year at the Liverpool Daily Post Regional Business Awards; and
December 2010
RedXpharma won New Technology Deal of the Year award at the Insider North West Dealmakers Awards. Acceleris were lead advisers to RedXpharma and led an equity fundraising under the Enterprise Investment Scheme for this company in Sept 2010 of £2m.
Advisory Partners Network (“the Network”)
The Network comprises successful entrepreneurs, business owners and senior level executives with whom the Seneca Capital team have trusted and long-standing relationships. The Seneca Capital team is able to call upon the knowledge and experience, which exists within the Network, when reviewing new investment opportunities and when managing portfolio investments. Members of the Network share the same passion and enthusiasm as the Seneca Capital team for helping businesses grow and use their contacts and experience to help Investee Companies thrive.
What Seneca says about itself
Seneca Capital was formed in 2010 bringing together a first class team of finance professionals with over 100 years of combined investment expertise, extensive contact networks and exceptional deal flow. Seneca Capital has a partnership with EIS specialist, Acceleris, to provide an EIS Portfolio Service for our investors. We have a dedicated team who specialise in private company equity investments targeting companies who can demonstrate sound underlying business fundamentals and strong growth potential.
Our focus is on helping established companies to grow and consequently we rarely engage with start-up businesses. Our EIS Portfolio Service targets well managed businesses that can demonstrate established and proven concepts, good balance sheet strength, profits or visibility of profit and cash generation, which are looking to take the next step in their growth phase.
The Seneca EIS Portfolio Service is a compelling investment option which combines the significant tax benefits available under the Enterprise Investment Scheme and the potential for attractive returns. We do not factor tax reliefs into our targeted investment returns and consider each opportunity on its merits regardless of the tax reliefs available.
How Seneca describes its investment process
Deals are introduced to us through our network of experienced professionals, entrepreneurs, corporate contacts and introducers or from a member of the Advisory Partners Network.
We typically review in excess of 500 investment opportunities, meet over 200 businesses every year and transact only a fraction of these. The application of strict investment criteria and extensive screening combined with detailed due diligence processes are designed to ensure that only the best investment opportunities are transacted for the Seneca EIS Portfolio Service.
Investment Criteria
Many of the investment opportunities that are received do not meet our investment criteria and therefore are not considered beyond initial review phase. The key investment criteria for our Portfolio Service investments are summarised below:
- Attractive growth prospects
- Defensible market position
- Realistic entry valuation expectations
- Strong underlying business fundamentals and management team
- Opportunity to enhance value from improved financial and operational practices and structures
- Exit available between 3 and 4 years
- Ability and desire to transact promptly
Investment Process
Those businesses that meet the majority, or indeed all, of the above investment criteria are then subject to our detailed investment process which is designed to identify issues that may not be apparent on initial review.
An overview of our investment process is included below:
Stage one:
Stage one consists of producing a summary of the potential deal including key features, market analysis, possible entry price, exit strategy, potential returns and key Due Diligence (DD) issues. Stage one highlights key concerns with the deal as well as an idea of DD costs and the potential deal structure. The paper is presented to the Investment Committee who either decline the opportunity or consent to investigating the opportunity further and moving to stage two.
Stage two:
Stage two consists of a full investigation of the investment opportunity, preparation of a full investment paper with DD findings (legal, commercial, management and financial), finalisation of deal structure and agreement of terms. Following a second stage approval from the Investment Committee, a summary of these findings is presented to the Portfolio Manager who then makes the final investment decision. After stage two approval, Seneca Capital move to deal completion followed by post deal ratification.
Post deal ratification and on-going management:
This involves six monthly updates to the Portfolio Manager from the Investment Adviser. The Investment Adviser reviews the management information on a monthly basis, monitors any underperformance and manages alignment to the exit strategy. When an exit offer is presented, the entire process is repeated before any sale is agreed or completed.
The Seneca team
The Seneca investment team is widely experienced and is one of the key competitive advantages of the Seneca service. It comprises:
IAN CURRIE is serial financial services entrepreneur who prior to founding Seneca Partners was head of Apax Corporate Finance then he built a group of fund management businesses containing over £350m of assets in corporate finance, private equity, stockbroking and pension administration.
MICHAEL BEVERLEY spent the first 28 years of his business career with Arthur Andersen during which time he rose to UK regional and senior managing partner responsible for 3,500 people, 11 offices and a turnover in excess of £350m. In 2001 he founded a range of businesses focused on healthcare and property. Since 2009 Michael has been chairman of One Medical, a developer of healthcare premises and One Medicare, a primary care service provider.
TIM MURPHY was founder of RBS Corporate and Structured Finance in 2002 before later becoming Corporate Finance Partner at Deloitte and subsequently UK Managing Director of large corporates at HBOS. He currently sits on the valuation committee of a major US special situations hedge fund;
NICK LEITCH started the Midlands operation of Endless LLP, the private equity house where he led origination, investment strategy and asset management across a number of high profile transactions and investments across a broad range of industry sectors;
STUART EATON has 25 years’ experience in Institutional Fund Management. He was previously head of UK equity alpha at Insight Investment for 5 years where he was responsible for managing £5billion of UK equities and was an active participant in portfolio analytics and risk management. Stuart has successfully invested in many sectors including small cap, unquoted and technology;
NORMAN MOLYNEUX qualified as a chartered management accountant with GKN in 1981, and completed a Masters Degree in Finance and Accounting in 2005. He is qualified under the Securities and Exchange Commission and prior to founding Acceleris Limited in 2000 worked at Price Waterhouse as a management consultant. Norman sits on a number of private company boards.
RICHARD MANLEY qualified as a chartered accountant with KMPG in 2003. He worked for KPMG for over 5 years, initially in their audit business and latterly in their corporate recovery division working on financial and operational restructurings and formal insolvencies. In 2007, Richard joined NM Rothschild’s leveraged finance team in Manchester before joining Cenkos Fund Managers in June 2008. During his time with Cenkos Fund Managers, he was manager of a £60m pre-IPO investment fund and gained extensive experience of fundraisings, mergers, acquisitions and restructurings.
ALEX DYMOCK is responsible for fundraising and on-going investor relations for Seneca investment offerings. Alex joined Seneca from Credit Suisse, where he worked with entrepreneurs across the UK on a variety of transactions both corporate and private. Before Credit Suisse, he worked at Goldman Sachs Asset Management and has an MBA from Manchester Business School.
IAN BATTERSBY was main board Director of an AIM listed Wealth Management Group until negotiating a partial MBO of the business in 2009. He has extensive experience in the wealth management and corporate banking sectors having previously held positions with Lloyds TSB Group and Hill Samuel. For more than 10 years Ian has worked exclusively with a first class network of HNWIs in the sport, music and entertainment sector and has wide experience of product and strategy development in these markets. Ian is responsible for Seneca’s relationships with Wealth Managers and Intermediaries and evolving investment strategies for HNWs.